EA201992558A1 - Варианты белка bmp7 человека - Google Patents
Варианты белка bmp7 человекаInfo
- Publication number
- EA201992558A1 EA201992558A1 EA201992558A EA201992558A EA201992558A1 EA 201992558 A1 EA201992558 A1 EA 201992558A1 EA 201992558 A EA201992558 A EA 201992558A EA 201992558 A EA201992558 A EA 201992558A EA 201992558 A1 EA201992558 A1 EA 201992558A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- bmp7
- relates
- present
- human protein
- options
- Prior art date
Links
- 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 230000007850 degeneration Effects 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 102000046107 human BMP7 Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2857—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, orphan receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Настоящее изобретение относится к новым вариантам белка BMP7 человека. Настоящее изобретение относится к векторам и клеткам-хозяевам для воспроизводства последовательностей нуклеиновой кислоты, кодирующих указанные белки, и их получения. Настоящее изобретение также относится к способам лечения злокачественного новообразования, повреждения и дегенерации хрящевой ткани, боли, ассоциированной с остеоартритом, или сращения кости.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762490910P | 2017-04-27 | 2017-04-27 | |
PCT/US2018/028496 WO2018200322A1 (en) | 2017-04-27 | 2018-04-20 | Variants of human bmp7 protein |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201992558A1 true EA201992558A1 (ru) | 2020-03-04 |
Family
ID=62196685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201992558A EA201992558A1 (ru) | 2017-04-27 | 2018-04-20 | Варианты белка bmp7 человека |
Country Status (17)
Country | Link |
---|---|
US (1) | US11466066B2 (ru) |
EP (1) | EP3615561B1 (ru) |
JP (1) | JP7308151B2 (ru) |
KR (1) | KR20200012870A (ru) |
CN (1) | CN110997708A (ru) |
AU (1) | AU2018258100B2 (ru) |
BR (1) | BR112019022566A2 (ru) |
CA (1) | CA3061606A1 (ru) |
CL (1) | CL2019003074A1 (ru) |
CO (1) | CO2019013150A2 (ru) |
CR (1) | CR20190539A (ru) |
EA (1) | EA201992558A1 (ru) |
MX (1) | MX2019012871A (ru) |
PE (1) | PE20200385A1 (ru) |
PH (1) | PH12019502442A1 (ru) |
SG (1) | SG11201910009UA (ru) |
WO (1) | WO2018200322A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12358963B2 (en) | 2019-12-24 | 2025-07-15 | Juvena Therapeutics, Inc. | Regenerative polypeptides and uses thereof |
JP2024525213A (ja) | 2021-06-21 | 2024-07-10 | ジュベナ セラピューティクス,インク. | 再生ポリペプチドおよびその使用 |
KR20230003879A (ko) | 2021-06-30 | 2023-01-06 | 현대자동차주식회사 | 하이브리드 차량의 림프홈 후진 주행 제어 시스템 및 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008500816A (ja) | 2004-03-31 | 2008-01-17 | ゼンコー・インコーポレイテッド | 改善された性質を有するbmp−7変異体 |
JP5452230B2 (ja) | 2006-12-21 | 2014-03-26 | ストライカー コーポレイション | 生物学的因子の結晶、高分子ゲルおよび粒子懸濁液を含む持続放出処方物 |
WO2008151258A2 (en) * | 2007-06-04 | 2008-12-11 | Neose Technologies, Inc. | O-linked glycosylation using n-acetylglucosaminyl transferases |
US7846428B2 (en) | 2007-10-05 | 2010-12-07 | Merial Limited | Articular cartilage gene therapy with recombinant vector encoding BMP-7 |
AU2008345689B2 (en) * | 2007-12-21 | 2013-04-18 | Stryker Corporation | BMP mutants with decreased susceptibility to Noggin |
-
2018
- 2018-04-20 EP EP18725687.0A patent/EP3615561B1/en active Active
- 2018-04-20 CR CR20190539A patent/CR20190539A/es unknown
- 2018-04-20 KR KR1020197035030A patent/KR20200012870A/ko not_active Withdrawn
- 2018-04-20 MX MX2019012871A patent/MX2019012871A/es unknown
- 2018-04-20 PE PE2019002134A patent/PE20200385A1/es unknown
- 2018-04-20 WO PCT/US2018/028496 patent/WO2018200322A1/en active IP Right Grant
- 2018-04-20 BR BR112019022566A patent/BR112019022566A2/pt not_active IP Right Cessation
- 2018-04-20 AU AU2018258100A patent/AU2018258100B2/en active Active
- 2018-04-20 SG SG11201910009U patent/SG11201910009UA/en unknown
- 2018-04-20 CA CA3061606A patent/CA3061606A1/en active Pending
- 2018-04-20 CN CN201880038790.9A patent/CN110997708A/zh active Pending
- 2018-04-20 JP JP2019558439A patent/JP7308151B2/ja active Active
- 2018-04-20 US US16/608,015 patent/US11466066B2/en active Active
- 2018-04-20 EA EA201992558A patent/EA201992558A1/ru unknown
-
2019
- 2019-10-25 CL CL2019003074A patent/CL2019003074A1/es unknown
- 2019-10-28 PH PH12019502442A patent/PH12019502442A1/en unknown
- 2019-11-25 CO CONC2019/0013150A patent/CO2019013150A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA3061606A1 (en) | 2018-11-01 |
AU2018258100A1 (en) | 2019-11-14 |
CN110997708A (zh) | 2020-04-10 |
EP3615561A1 (en) | 2020-03-04 |
US20210115100A1 (en) | 2021-04-22 |
WO2018200322A1 (en) | 2018-11-01 |
JP2020517706A (ja) | 2020-06-18 |
SG11201910009UA (en) | 2019-11-28 |
BR112019022566A2 (pt) | 2020-05-19 |
EP3615561C0 (en) | 2024-01-10 |
CR20190539A (es) | 2020-03-26 |
MX2019012871A (es) | 2021-01-08 |
EP3615561B1 (en) | 2024-01-10 |
AU2018258100B2 (en) | 2022-04-14 |
PH12019502442A1 (en) | 2020-10-05 |
CO2019013150A2 (es) | 2020-02-28 |
CL2019003074A1 (es) | 2020-05-08 |
KR20200012870A (ko) | 2020-02-05 |
JP7308151B2 (ja) | 2023-07-13 |
US11466066B2 (en) | 2022-10-11 |
PE20200385A1 (es) | 2020-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201892561A1 (ru) | Гибридные белки gdf15 и их применение | |
PH12019500122A1 (en) | Bispecific antibody-like binding proteins specifically binding to cd3 and cd123 | |
EA201892616A1 (ru) | Антитела к pd1 и lag3 для лечения злокачественного новообразования | |
EA201792573A1 (ru) | Триспецифические связанные белки и способы их применения | |
EA202091995A1 (ru) | Композиции и способы лечения не связанного с возрастом нарушения слуха у субъекта-человека | |
JOP20220079A1 (ar) | بروتين ربط متعددة الخصوصية لمعالجة السرطان | |
EA202090817A1 (ru) | Триспецифические белки и способы их применения | |
EA201992063A1 (ru) | СВЯЗЫВАЮЩИЕ ErbB-2 И ErbB-3 БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА ДЛЯ ПРИМЕНЕНИЯ ДЛЯ ЛЕЧЕНИЯ КЛЕТОК, КОТОРЫЕ СОДЕРЖАТ СЛИТЫЙ ГЕН NRG-1 | |
EA201890640A1 (ru) | Рекомбинантные векторы, содержащие пептид 2а | |
MX2021015182A (es) | Casetes optimizados de expresion del gen humano del factor viii de coagulacion y su uso. | |
MX395421B (es) | Moleculas de acido nucleico artificiales. | |
EA201690529A1 (ru) | Способы модификации клетки-хозяина | |
MY199683A (en) | Anti-pd-1 antibodies | |
MX385207B (es) | Aglutinantes de tnf mejorados. | |
MX2024014468A (es) | Anticuerpos anti-cd63, conjugados y usos de estos | |
PH12022550460A1 (en) | Anti-cd96 antibodies and methods of use thereof | |
PH12020550099A1 (en) | Fusion protein comprising an fgf-18 moiety | |
EA201992558A1 (ru) | Варианты белка bmp7 человека | |
PH12020550483A1 (en) | Anti-apoc3 antibodies and methods of use thereof | |
EA201792274A1 (ru) | Слитые молекулы вариант iii рецептора эпидермального фактора роста-мезотелин и способы их применения | |
PH12019502449A1 (en) | Anti-jagged1 antigen binding proteins | |
MX2015012281A (es) | Proteinas de union a tnf mejoradas. | |
WO2016160976A3 (en) | Monovalent tnf binding proteins | |
EA202092769A1 (ru) | Антитела против cd63, их конъюгаты и применения | |
EA201991181A1 (ru) | Psma-нацеленные триспецифические белки и способы их применения |